2 0 1 0 1 B-lower_bound
weeks 2 7 2 7 I-lower_bound
or 8 10 8 10 O
more 11 15 11 15 O
since 16 21 16 21 O
end 22 25 22 25 O
of 26 28 26 28 O
previous 29 37 29 37 B-treatment
systemic 38 46 38 46 I-treatment
treatment 47 56 47 56 I-treatment
( 57 58 57 58 O
4 58 59 58 59 B-lower_bound
weeks 60 65 60 65 I-lower_bound
or 66 68 66 68 O
more 69 73 69 73 O
for 74 77 74 77 O
bevacizumab 78 89 78 89 B-treatment
plus 90 94 90 94 I-treatment
interferon 95 105 95 105 I-treatment
- 105 106 105 106 I-treatment
alfa 106 110 106 110 I-treatment
) 110 111 110 111 O

3 0 1 112 113 O
days 2 6 114 118 O
wash 7 11 119 123 O
out 12 15 124 127 O
for 16 19 128 131 O
palliative 20 30 132 142 B-treatment
radiation 31 40 143 152 I-treatment

Adequate 0 8 153 161 O
hematological 9 22 162 175 O
lab 23 26 176 179 O
values 27 33 180 186 O
including 34 43 187 196 O
: 43 44 196 197 O
Absolute 45 53 198 206 B-clinical_variable
Neutrophil 54 64 207 217 I-clinical_variable
Count 65 70 218 223 I-clinical_variable
( 71 72 224 225 I-clinical_variable
ANC 72 75 225 228 I-clinical_variable
) 75 76 228 229 I-clinical_variable
≥ 77 78 230 231 O
1.0 79 82 232 235 B-lower_bound
x 83 84 236 237 I-lower_bound
109 85 88 238 241 I-lower_bound
/ 88 89 241 242 I-lower_bound
L 89 90 242 243 I-lower_bound
, 90 91 243 244 O
Platelets 92 101 245 254 B-clinical_variable
≥ 102 103 255 256 O
100 104 107 257 260 B-lower_bound
x 108 109 261 262 I-lower_bound
109 110 113 263 266 I-lower_bound
/ 113 114 266 267 I-lower_bound
L 114 115 267 268 I-lower_bound
, 115 116 268 269 O
Hemoglobin 117 127 270 280 B-clinical_variable
≥ 128 129 281 282 O
9.0 130 133 283 286 B-lower_bound
g 134 135 287 288 I-lower_bound
/ 135 136 288 289 I-lower_bound
dL 136 138 289 291 I-lower_bound

Age 0 3 292 295 B-age
of 4 6 296 298 O
at 7 9 299 301 O
least 10 15 302 307 O
18 16 18 308 310 B-lower_bound
years 19 24 311 316 I-lower_bound

Any 0 3 317 320 O
other 4 9 321 326 O
cancer 10 16 327 333 B-cancer
from 17 21 334 338 O
which 22 27 339 344 O
the 28 31 345 348 O
patient 32 39 349 356 O
has 40 43 357 360 O
been 44 48 361 365 O
disease 49 56 366 373 O
- 56 57 373 374 O
free 57 61 374 378 O
for 62 65 379 382 O
less 66 70 383 387 O
than 71 75 388 392 O
5 76 77 393 394 B-upper_bound
years 78 83 395 400 I-upper_bound
( 84 85 401 402 O
except 85 91 402 408 O
treated 92 99 409 416 O
and 100 103 417 420 O
cured 104 109 421 426 O
basal 110 115 427 432 B-cancer
- 115 116 432 433 I-cancer
cell 116 120 433 437 I-cancer
or 121 123 438 440 O
squamous 124 132 441 449 B-cancer
- 132 133 449 450 I-cancer
cell 133 137 450 454 I-cancer
skin 138 142 455 459 I-cancer
cancer 143 149 460 466 I-cancer
, 149 150 466 467 O
superficial 151 162 468 479 B-cancer
bladder 163 170 480 487 I-cancer
cancer 171 177 488 494 I-cancer
, 177 178 494 495 O
or 179 181 496 498 O
treated 182 189 499 506 O
carcinoma 190 199 507 516 B-cancer
in 200 202 517 519 I-cancer
situ 203 207 520 524 I-cancer
of 208 210 525 527 I-cancer
the 211 214 528 531 I-cancer
cervix 215 221 532 538 I-cancer
, 221 222 538 539 O
breast 223 229 540 546 B-cancer
, 229 230 546 547 O
or 231 233 548 550 O
bladder 234 241 551 558 O
and 242 245 559 562 O
treated 246 253 563 570 O
localized 254 263 571 580 O
prostate 264 272 581 589 B-cancer
cancer 273 279 590 596 I-cancer
with 280 284 597 601 O
undetectable 285 297 602 614 O
PSA 298 301 615 618 O
for 302 305 619 622 O
2 306 307 623 624 B-upper_bound
years 308 313 625 630 I-upper_bound
) 313 314 630 631 O

Eastern 0 7 632 639 B-clinical_variable
Cooperative 8 19 640 651 I-clinical_variable
Oncology 20 28 652 660 I-clinical_variable
Group 29 34 661 666 I-clinical_variable
( 35 36 667 668 I-clinical_variable
ECOG 36 40 668 672 I-clinical_variable
) 40 41 672 673 I-clinical_variable
performance 42 53 674 685 I-clinical_variable
status 54 60 686 692 I-clinical_variable
of 61 63 693 695 O
0 64 65 696 697 B-lower_bound
( 66 67 698 699 O
fully 67 72 699 704 O
active 73 79 705 711 O
, 79 80 711 712 O
able 81 85 713 717 O
to 86 88 718 720 O
carry 89 94 721 726 O
on 95 97 727 729 O
all 98 101 730 733 O
pre 102 105 734 737 O
- 105 106 737 738 O
disease 106 113 738 745 O
performance 114 125 746 757 O
without 126 133 758 765 O
restriction 134 145 766 777 O
) 145 146 777 778 O
or 147 149 779 781 O
1 150 151 782 783 B-upper_bound
( 152 153 784 785 O
restricted 153 163 785 795 O
in 164 166 796 798 O
physically 167 177 799 809 O
strenuous 178 187 810 819 O
activity 188 196 820 828 O
but 197 200 829 832 O
ambulatory 201 211 833 843 O
and 212 215 844 847 O
able 216 220 848 852 O
to 221 223 853 855 O
carry 224 229 856 861 O
out 230 233 862 865 O
work 234 238 866 870 O
of 239 241 871 873 O
a 242 243 874 875 O
light 244 249 876 881 O
or 250 252 882 884 O
sedentary 253 262 885 894 O
nature 263 269 895 901 O
, 269 270 901 902 O
such 271 275 903 907 O
as 276 278 908 910 O
light 279 284 911 916 O
housework 285 294 917 926 O
or 295 297 927 929 O
office 298 304 930 936 O
work 305 309 937 941 O
) 309 310 941 942 O
or 311 313 943 945 O
2 314 315 946 947 O
( 316 317 948 949 O
Ambulatory 317 327 949 959 O
and 328 331 960 963 O
capable 332 339 964 971 O
of 340 342 972 974 O
all 343 346 975 978 O
self 347 351 979 983 O
- 351 352 983 984 O
care 352 356 984 988 O
but 357 360 989 992 O
unable 361 367 993 999 O
to 368 370 1000 1002 O
carry 371 376 1003 1008 O
out 377 380 1009 1012 O
any 381 384 1013 1016 O
work 385 389 1017 1021 O
activities 390 400 1022 1032 O

Known 0 5 1033 1038 O
HIV 6 9 1039 1042 B-chronic_disease
or 10 12 1043 1045 O
acquired 13 21 1046 1054 B-chronic_disease
immunodeficiency 22 38 1055 1071 I-chronic_disease
syndrome 39 47 1072 1080 I-chronic_disease
- 47 48 1080 1081 O
related 48 55 1081 1088 O
disease 56 63 1089 1096 O

Life 0 4 1097 1101 B-clinical_variable
expectancy 5 15 1102 1112 I-clinical_variable
of 16 18 1113 1115 O
12 19 21 1116 1118 B-lower_bound
weeks 22 27 1119 1124 I-lower_bound
and 28 31 1125 1128 O
more 32 36 1129 1133 O

Liver 0 5 1134 1139 O
function 6 14 1140 1148 O
( 15 16 1149 1150 O
AST 16 19 1150 1153 B-clinical_variable
/ 19 20 1153 1154 I-clinical_variable
ALT 20 23 1154 1157 I-clinical_variable
< 24 25 1158 1159 O
2.5 25 28 1159 1162 B-upper_bound
X 29 30 1163 1164 I-upper_bound
institutional 31 44 1165 1178 I-upper_bound
upper 45 50 1179 1184 I-upper_bound
limit 51 56 1185 1190 I-upper_bound
of 57 59 1191 1193 I-upper_bound
normal 60 66 1194 1200 I-upper_bound
OR 67 69 1201 1203 O
< 70 71 1204 1205 O
5 71 72 1205 1206 O
X 73 74 1207 1208 O
institutional 75 88 1209 1222 O
upper 89 94 1223 1228 O
limit 95 100 1229 1234 O
of 101 103 1235 1237 O
normal 104 110 1238 1244 O
in 111 113 1245 1247 O
cases 114 119 1248 1253 O
of 120 122 1254 1256 O
liver 123 128 1257 1262 B-cancer
metastases 129 139 1263 1273 I-cancer
; 139 140 1273 1274 O
Total 141 146 1275 1280 B-clinical_variable
bilirubin 147 156 1281 1290 I-clinical_variable
≤ 157 158 1291 1292 O
1.5 159 162 1293 1296 B-upper_bound
times 163 168 1297 1302 I-upper_bound
ULN 169 172 1303 1306 I-upper_bound
. 172 173 1306 1307 O
) 173 174 1307 1308 O

Major 0 5 1309 1314 B-treatment
surgery 6 13 1315 1322 I-treatment
within 14 20 1323 1329 O
4 21 22 1330 1331 B-upper_bound
weeks 23 28 1332 1337 I-upper_bound
of 29 31 1338 1340 O
starting 32 40 1341 1349 O
study 41 46 1350 1355 O
treatment 47 56 1356 1365 B-treatment

Myocardial 0 10 1366 1376 B-chronic_disease
infarction 11 21 1377 1387 I-chronic_disease
, 21 22 1387 1388 O
uncontrolled 23 35 1389 1401 B-chronic_disease
angina 36 42 1402 1408 I-chronic_disease
, 42 43 1408 1409 O
congestive 44 54 1410 1420 B-chronic_disease
heart 55 60 1421 1426 I-chronic_disease
failure 61 68 1427 1434 I-chronic_disease
, 68 69 1434 1435 O
or 70 72 1436 1438 O
cerebrovascular 73 88 1439 1454 B-chronic_disease
accident 89 97 1455 1463 O
within 98 104 1464 1470 O
previous 105 113 1471 1479 O
12 114 116 1480 1482 B-upper_bound
months 117 123 1483 1489 I-upper_bound

Pre 0 3 1490 1493 O
- 3 4 1493 1494 O
existing 4 12 1494 1502 O
uncontrolled 13 25 1503 1515 B-clinical_variable
hypertension 26 38 1516 1528 I-clinical_variable
defined 39 46 1529 1536 O
as 47 49 1537 1539 O
> 50 51 1540 1541 O
150/90 52 58 1542 1548 B-lower_bound
mm 59 61 1549 1551 I-lower_bound
Hg 62 64 1552 1554 I-lower_bound
with 65 69 1555 1559 O
medication 70 80 1560 1570 B-treatment

Present 0 7 1571 1578 O
use 8 11 1579 1582 O
or 12 14 1583 1585 O
anticipated 15 26 1586 1597 O
need 27 31 1598 1602 O
for 32 35 1603 1606 O
cytochrome 36 46 1607 1617 B-treatment
P450 47 51 1618 1622 I-treatment
( 52 53 1623 1624 I-treatment
CYP 53 56 1624 1627 I-treatment
) 56 57 1627 1628 I-treatment
3A4 58 61 1629 1632 I-treatment
- 61 62 1632 1633 I-treatment
inhibiting 62 72 1633 1643 I-treatment
, 72 73 1643 1644 O
CYP3A4 74 80 1645 1651 B-treatment
- 80 81 1651 1652 I-treatment
inducing 81 89 1652 1660 I-treatment
drugs 90 95 1661 1666 I-treatment
( 96 97 1667 1668 O
e.g. 97 101 1668 1672 O
, 101 102 1672 1673 O
ketoconazole 103 115 1674 1686 B-treatment
, 115 116 1686 1687 O
itraconazole 117 129 1688 1700 B-treatment
, 129 130 1700 1701 O
clarithromycin 131 145 1702 1716 B-treatment
, 145 146 1716 1717 O
atazanavir 147 157 1718 1728 B-treatment
, 157 158 1728 1729 O
indinavir 159 168 1730 1739 B-treatment
, 168 169 1739 1740 O
nefazodone 170 180 1741 1751 B-treatment
, 180 181 1751 1752 O
nelfinavir 182 192 1753 1763 B-treatment
, 192 193 1763 1764 O
ritonavir 194 203 1765 1774 B-treatment
, 203 204 1774 1775 O
saquinavir 205 215 1776 1786 B-treatment
, 215 216 1786 1787 O
telithromycin 217 230 1788 1801 B-treatment
, 230 231 1801 1802 O
and 232 235 1803 1806 O
voriconazole 236 248 1807 1819 B-treatment
, 248 249 1819 1820 O
rifampin 250 258 1821 1829 B-treatment
, 258 259 1829 1830 O
phenytoin 260 269 1831 1840 B-treatment
, 269 270 1840 1841 O
carbamazepine 271 284 1842 1855 B-treatment
, 284 285 1855 1856 O
rifabutin 286 295 1857 1866 B-treatment
, 295 296 1866 1867 O
rifapentin 297 307 1868 1878 B-treatment
, 307 308 1878 1879 O
phenobarbital 309 322 1880 1893 B-treatment
, 322 323 1893 1894 O
and 324 327 1895 1898 O
St. 328 331 1899 1902 B-treatment
John 332 336 1903 1907 I-treatment
's 336 338 1907 1909 I-treatment
wort 339 343 1910 1914 I-treatment
, 343 344 1914 1915 O
bosentan 345 353 1916 1924 B-treatment
, 353 354 1924 1925 O
efavirenz 355 364 1926 1935 B-treatment
, 364 365 1935 1936 O
etravirine 366 376 1937 1947 B-treatment
, 376 377 1947 1948 O
modafinil 378 387 1949 1958 B-treatment
, 387 388 1958 1959 O
and 389 392 1960 1963 O
nafcillin 393 402 1964 1973 B-treatment
) 402 403 1973 1974 O

Renal 0 5 1975 1980 O
function 6 14 1981 1989 O
( 15 16 1990 1991 O
creatinine 16 26 1991 2001 O
level 27 32 2002 2007 O
within 33 39 2008 2014 O
normal 40 46 2015 2021 O
institutional 47 60 2022 2035 O
limit 61 66 2036 2041 O
, 66 67 2041 2042 O
or 68 70 2043 2045 O
creatinine 71 81 2046 2056 B-clinical_variable
clearance 82 91 2057 2066 I-clinical_variable
> 92 93 2067 2068 O
15 93 95 2068 2070 B-lower_bound
mL 96 98 2071 2073 I-lower_bound
/ 98 99 2073 2074 I-lower_bound
min/1.73 99 107 2074 2082 I-lower_bound
m2 108 110 2083 2085 I-lower_bound
for 111 114 2086 2089 O
patients 115 123 2090 2098 O
with 124 128 2099 2103 O
creatinine 129 139 2104 2114 O
levels 140 146 2115 2121 O
above 147 152 2122 2127 O
institutional 153 166 2128 2141 O
normal 167 173 2142 2148 O
, 173 174 2148 2149 O
calculated 175 185 2150 2160 O
using 186 191 2161 2166 O
the 192 195 2167 2170 O
Cockcroft 196 205 2171 2180 O
- 205 206 2180 2181 O
Gault 206 211 2181 2186 O
formula 212 219 2187 2194 O
) 219 220 2194 2195 O

Symptomatic 0 11 2196 2207 O
untreated 12 21 2208 2217 O
metastases 22 32 2218 2228 B-cancer
in 33 35 2229 2231 I-cancer
the 36 39 2232 2235 I-cancer
central 40 47 2236 2243 I-cancer
nervous 48 55 2244 2251 I-cancer
system 56 62 2252 2258 I-cancer

pregnant 0 8 2259 2267 B-pregnancy

